Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normalizing Platelet Reactivity After Treatment With Ticagrelor
NCT02201394Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by Icahn School of Medicine at Mount Sinai. Started Jul 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02201394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201394.